TY - JOUR AU - Comas, I. AU - Coscolla, M. AU - Luo, T. AU - Borrell, S. AU - Holt, K. E. AU - Kato-Maeda, M. PY - 2013 DA - 2013// TI - Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans JO - Nat Genet VL - 45 UR - https://doi.org/10.1038/ng.2744 DO - 10.1038/ng.2744 ID - Comas2013 ER - TY - JOUR AU - Leibert, E. AU - Rom, W. N. PY - 2010 DA - 2010// TI - New drugs and regimens for treatment of TB JO - Expert Rev Anti Infect Ther VL - 8 UR - https://doi.org/10.1586/eri.10.60 DO - 10.1586/eri.10.60 ID - Leibert2010 ER - TY - JOUR PY - 2013 DA - 2013// TI - Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis JO - MMWR Recomm Rep VL - 62 ID - ref3 ER - TY - BOOK PY - 2013 DA - 2013// TI - Multidrug-resistant TB (MDR-TB): 2013 Update ID - ref4 ER - TY - STD TI - Organization GWH. The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance. WHO Guidelines Approved by the Guidelines Review Committee 2013. ID - ref5 ER - TY - JOUR AU - Ahmad, S. AU - Mokaddas, E. PY - 2014 DA - 2014// TI - Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis JO - J Infect Public Health VL - 7 UR - https://doi.org/10.1016/j.jiph.2013.09.001 DO - 10.1016/j.jiph.2013.09.001 ID - Ahmad2014 ER - TY - JOUR AU - Pontali, E. AU - Matteelli, A. AU - Migliori, G. B. PY - 2013 DA - 2013// TI - Drug-resistant tuberculosis JO - Curr Opin Pulm Med VL - 19 UR - https://doi.org/10.1097/MCP.0b013e32835f1bf3 DO - 10.1097/MCP.0b013e32835f1bf3 ID - Pontali2013 ER - TY - STD TI - The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance. Geneva: World Health Organization; 2013. ID - ref8 ER - TY - JOUR AU - Ryan, N. J. AU - Lo, J. H. PY - 2014 DA - 2014// TI - Delamanid: first global approval JO - Drugs VL - 74 UR - https://doi.org/10.1007/s40265-014-0241-5 DO - 10.1007/s40265-014-0241-5 ID - Ryan2014 ER - TY - JOUR AU - Lauzardo, M. AU - Peloquin, C. A. PY - 2012 DA - 2012// TI - Antituberculosis therapy for 2012 and beyond JO - Expert Opin Pharmacother VL - 13 UR - https://doi.org/10.1517/14656566.2012.657176 DO - 10.1517/14656566.2012.657176 ID - Lauzardo2012 ER - TY - JOUR AU - Wallis, R. S. PY - 2012 DA - 2012// TI - Sustainable tuberculosis drug development JO - Clin Infect Dis VL - 56 UR - https://doi.org/10.1093/cid/cis849 DO - 10.1093/cid/cis849 ID - Wallis2012 ER - TY - JOUR AU - Dutta, N. K. AU - Karakousis, P. C. PY - 2012 DA - 2012// TI - Tuberculosis chemotherapy : present situation, possible solutions, and progress towards a TB-free world JO - Indian J Med Microbiol VL - 30 UR - https://doi.org/10.4103/0255-0857.99481 DO - 10.4103/0255-0857.99481 ID - Dutta2012 ER - TY - JOUR AU - Cipriani, A. AU - Barbui, C. AU - Salanti, G. AU - Rendell, J. AU - Brown, R. AU - Stockton, S. PY - 2011 DA - 2011// TI - Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis JO - Lancet VL - 378 UR - https://doi.org/10.1016/S0140-6736(11)60873-8 DO - 10.1016/S0140-6736(11)60873-8 ID - Cipriani2011 ER - TY - JOUR AU - Cannon, C. P. AU - Steinberg, B. A. AU - Murphy, S. A. AU - Mega, J. L. AU - Braunwald, E. PY - 2006 DA - 2006// TI - Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy JO - J Am Coll Cardiol VL - 48 UR - https://doi.org/10.1016/j.jacc.2006.04.070 DO - 10.1016/j.jacc.2006.04.070 ID - Cannon2006 ER - TY - JOUR AU - Liu, J. AU - Dong, J. AU - Wang, L. AU - Su, Y. AU - Yan, P. AU - Sun, S. PY - 2013 DA - 2013// TI - Comparative efficacy and acceptability of antidepressants in Parkinson’s disease: a network meta-analysis JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0076651 DO - 10.1371/journal.pone.0076651 ID - Liu2013 ER - TY - JOUR AU - Cipriani, A. AU - Furukawa, T. A. AU - Salanti, G. AU - Geddes, J. R. AU - Higgins, J. P. AU - Churchill, R. PY - 2009 DA - 2009// TI - Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60046-5 DO - 10.1016/S0140-6736(09)60046-5 ID - Cipriani2009 ER - TY - JOUR AU - Osborne, R. PY - 2013 DA - 2013// TI - First novel anti-tuberculosis drug in 40 years JO - Nat Biotechnol VL - 31 UR - https://doi.org/10.1038/nbt0213-89 DO - 10.1038/nbt0213-89 ID - Osborne2013 ER - TY - JOUR AU - Lumley, T. PY - 2002 DA - 2002// TI - Network meta-analysis for indirect treatment comparisons JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1201 DO - 10.1002/sim.1201 ID - Lumley2002 ER - TY - JOUR AU - Leucht, S. AU - Cipriani, A. AU - Spineli, L. AU - Mavridis, D. AU - Orey, D. AU - Richter, F. PY - 2013 DA - 2013// TI - Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis JO - Lancet VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)60733-3 DO - 10.1016/S0140-6736(13)60733-3 ID - Leucht2013 ER - TY - JOUR AU - Lee, J. AU - Lee, C. H. AU - Kim, D. K. AU - Yoon, H. I. AU - Kim, J. Y. AU - Lee, S. M. PY - 2011 DA - 2011// TI - Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes JO - Korean J Intern Med VL - 26 UR - https://doi.org/10.3904/kjim.2011.26.2.153 DO - 10.3904/kjim.2011.26.2.153 ID - Lee2011 ER - TY - JOUR AU - Jiang, R. H. AU - Xu, H. B. AU - Li, L. PY - 2013 DA - 2013// TI - Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study JO - Int J Antimicrob Agents VL - 42 UR - https://doi.org/10.1016/j.ijantimicag.2013.02.019 DO - 10.1016/j.ijantimicag.2013.02.019 ID - Jiang2013 ER - TY - JOUR AU - Diacon, A. H. AU - Donald, P. R. AU - Pym, A. AU - Grobusch, M. AU - Patientia, R. F. AU - Mahanyele, R. PY - 2012 DA - 2012// TI - Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance JO - Antimicrob Agents Chemother VL - 56 UR - https://doi.org/10.1128/AAC.06126-11 DO - 10.1128/AAC.06126-11 ID - Diacon2012 ER - TY - JOUR AU - Diacon, A. H. AU - Pym, A. AU - Grobusch, M. AU - Patientia, R. AU - Rustomjee, R. AU - Page-Shipp, L. PY - 2009 DA - 2009// TI - The diarylquinoline TMC207 for multidrug-resistant tuberculosis JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0808427 DO - 10.1056/NEJMoa0808427 ID - Diacon2009 ER - TY - STD TI - BVBA JID. TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB). Clinical Trialsgov. 2013. (https://www.clinicaltrials.gov/ct2/results?term=+Anti-bacterial+Activity%2C+Safety%2C+and+Tolerability+of+TMC207+in+Participants+With+Multi-drug+Resistant+Mycobacterium+Tuberculosis+%28MDR-TB%29&Search=Search) UR - https://www.clinicaltrials.gov/ct2/results?term=+Anti-bacterial+Activity%2C+Safety%2C+and+Tolerability+of+TMC207+in+Participants+With+Multi-drug+Resistant+Mycobacterium+Tuberculosis+%28MDR-TB%29&Search=Search ID - ref24 ER - TY - JOUR AU - Gler, M. T. AU - Skripconoka, V. AU - Sanchez-Garavito, E. AU - Xiao, H. AU - Cabrera-Rivero, J. L. AU - Vargas-Vasquez, D. E. PY - 2012 DA - 2012// TI - Delamanid for multidrug-resistant pulmonary tuberculosis JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1112433 DO - 10.1056/NEJMoa1112433 ID - Gler2012 ER - TY - STD TI - Otsuka Pharmaceutical Development & Commercialization I. A Placebo-controlled, Phase 2 Trial to Evaluate OPC 67683 in Patients With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB). Clinical Trialsgov. 2011. (https://www.clinicaltrials.gov/ct2/results?term=A+Placebo-controlled%2C+Phase+2+Trial+to+Evaluate+OPC+67683+in+Patients+With+Pulmonary+Sputum+Culture-positive%2C+Multidrug-resistant+Tuberculosis+&Search=Search) UR - https://www.clinicaltrials.gov/ct2/results?term=A+Placebo-controlled%2C+Phase+2+Trial+to+Evaluate+OPC+67683+in+Patients+With+Pulmonary+Sputum+Culture-positive%2C+Multidrug-resistant+Tuberculosis+&Search=Search ID - ref26 ER - TY - JOUR AU - Skripconoka, V. AU - Danilovits, M. AU - Pehme, L. AU - Tomson, T. AU - Skenders, G. AU - Kummik, T. PY - 2012 DA - 2012// TI - Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis JO - Eur Respir J VL - 41 UR - https://doi.org/10.1183/09031936.00125812 DO - 10.1183/09031936.00125812 ID - Skripconoka2012 ER - TY - JOUR AU - Zhang, Q. AU - Liu, Y. AU - Tang, S. AU - Sha, W. AU - Xiao, H. PY - 2013 DA - 2013// TI - Clinical benefit of delamanid (OPC-67683) in the treatment of multidrug-resistant tuberculosis patients in China JO - Cell Biochem Biophys VL - 67 UR - https://doi.org/10.1007/s12013-013-9589-5 DO - 10.1007/s12013-013-9589-5 ID - Zhang2013 ER - TY - JOUR AU - Carroll, M. W. AU - Jeon, D. AU - Mountz, J. M. AU - Lee, J. D. AU - Jeong, Y. J. AU - Zia, N. PY - 2013 DA - 2013// TI - Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.00753-13 DO - 10.1128/AAC.00753-13 ID - Carroll2013 ER - TY - STD TI - Center NIoHC. Metronidazole for pulmonary tuberculosis (South Korea). Clinical Trialsgov 2013. (https://www.clinicaltrials.gov/ct2/results?term=Metronidazole+for+pulmonary+tuberculosis+%28South+Korea%29&Search=Search) UR - https://www.clinicaltrials.gov/ct2/results?term=Metronidazole+for+pulmonary+tuberculosis+%28South+Korea%29&Search=Search ID - ref30 ER - TY - STD TI - University JH. Moxifloxacin as part of a multi-drug regimen for tuberculosis. Clinical Trialsgov. 2013.( https://www.clinicaltrials.gov/ct2/show/NCT00082173?term=Moxifloxacin+as+part+of+a+multi-drug+regimen+for+tuberculosis&rank=1) UR - https://www.clinicaltrials.gov/ct2/show/NCT00082173?term=Moxifloxacin+as+part+of+a+multi-drug+regimen+for+tuberculosis&rank=1 ID - ref31 ER - TY - JOUR AU - Chen, Y. PY - 2013 DA - 2013// TI - Effects of moxifloxacin combined with regimenin the treatment of patients with drug-resistant pulmonary tuberculosis JO - J Clin Pulm Med VL - 18 ID - Chen2013 ER - TY - JOUR AU - Koh, W. J. AU - Lee, S. H. AU - Kang, Y. A. AU - Lee, C. H. AU - Choi, J. C. AU - Lee, J. H. PY - 2013 DA - 2013// TI - Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis JO - Am J Respir Crit Care Med VL - 188 UR - https://doi.org/10.1164/rccm.201303-0604OC DO - 10.1164/rccm.201303-0604OC ID - Koh2013 ER - TY - STD TI - Hospital SNU. Comparison of the effect between levofloxacin and moxifloxacin among MDR-TB patients. Clinical Trialsgov. 2012. (https://www.clinicaltrials.gov/ct2/results?term=Comparison+of+the+effect+between+levofloxacin+and+moxifloxacin+among+MDR-TB+patients&Search=Search) UR - https://www.clinicaltrials.gov/ct2/results?term=Comparison+of+the+effect+between+levofloxacin+and+moxifloxacin+among+MDR-TB+patients&Search=Search ID - ref34 ER - TY - JOUR AU - Liang, L. PY - 2011 DA - 2011// TI - Effects of anti-tuberculosis containing with moxifloxacin or levofloxacin on multidrug resistant pulmonary tuberculosis JO - Chin Gen Pract VL - 14 ID - Liang2011 ER -